Watson CEO OK'd To Quiz FTC In Subpoena Dustup

By Pete Brush (July 14, 2010, 7:25 PM EDT) -- Watson Pharmaceuticals Inc. CEO Paul M. Bisaro has won a bid to conduct discovery into whether the Federal Trade Commission shared confidential information with a rival of the generic-drug maker in an effort to force Bisaro to testify in a competition probe triggered by a patent case settlement over the narcolepsy treatment Provigil....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as